Scinai Immunotherapeutics Ltd. SEC filings SCNI
Scinai Immunotherapeutics Ltd. has 495 filings in SEC EDGAR's recent list, going back to Nov 13, 2014. Its latest annual report, Form 20-F, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on May 15, 2023, covering the quarter ended Mar 31, 2023. The most recent current report (Form 6-K) was filed on Oct 20, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| F-3 | Shelf registration (foreign issuer) | Oct 28, 2026 | — |
| F-1 | Registration statement (foreign issuer) | Sep 24, 2026 | — |
| POS AM | Post-effective amendment no. 1 to form f-1 | Aug 27, 2026 | — |
| 424B3 | Prospectus | May 19, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | May 8, 2026 | — |
| S-8 | Employee stock plan registration | Nov 12, 2025 | — |
| 424B3 | Prospectus | Oct 6, 2025 | — |
| F-1 | Registration statement (foreign issuer) | Sep 22, 2025 | — |
| POS AM | Post-effective amendment no. 2 to form f-1 | Sep 4, 2025 | — |
| 424B3 | Prospectus | Jun 5, 2025 | — |
| POS AM | Post-effective amendment no. 1 to form f-1 | May 12, 2025 | — |
| 424B3 | Prospectus | Mar 13, 2025 | — |
| F-1/A | Amendment no. 1 to form f-1 | Mar 11, 2025 | — |
| F-1 | Registration statement (foreign issuer) | Mar 4, 2025 | — |
| 424B3 | Prospectus | May 16, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Jan 30, 2024 | — |
| 424B3 | Prospectus | Jan 2, 2024 | — |
| 424B3 | Prospectus | Jan 2, 2024 | — |
| 424B3 | Prospectus | Jan 2, 2024 | — |
| F-1/A | Amendment no. 1 to form f-1 | Dec 22, 2023 | — |
| F-1 | Registration statement (foreign issuer) | Oct 30, 2023 | — |
| 424B5 | Prospectus supplement | Sep 19, 2023 | — |
| 424B3 | Prospectus | Sep 7, 2023 | — |
| 424B2 | Prospectus | Aug 28, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 18, 2023 | — |
| S-8 | Employee stock plan registration | Apr 17, 2023 | — |
| 424B4 | Prospectus | Dec 20, 2022 | — |
| F-1/A | Amendment no. 2 to form f-1 | Dec 14, 2022 | — |
| F-1/A | Amendment no. 1 to form f-1 | Dec 12, 2022 | — |
| 424B3 | Prospectus | Nov 16, 2022 | — |
| F-1 | Registration statement (foreign issuer) | Sep 29, 2022 | — |
| 424B5 | Prospectus supplement | Dec 28, 2021 | — |
| 424B5 | Prospectus supplement | Dec 27, 2021 | — |
| 424B5 | Prospectus supplement | Feb 1, 2021 | — |
| 424B5 | Prospectus supplement | Jan 29, 2021 | — |
| 424B5 | Prospectus supplement | Oct 2, 2020 | — |
| F-3 | Shelf registration (foreign issuer) | Jul 29, 2020 | — |
| S-8 | Employee stock plan registration | Jun 22, 2020 | — |
| POS AM | Post-effective amendment no. 4 to registration statement | Jan 7, 2020 | — |
| F-1/A | Amendment no. 4 to form f-1 | Jun 7, 2019 | — |
| F-1/A | Amendment no. 3 to form f-1 | Jun 6, 2019 | — |
| F-1/A | Amendment no. 2 to registration statement | May 30, 2019 | — |
| F-1/A | Amendment no. 1 to form f-1/a | May 6, 2019 | — |
| F-1 | Registration statement (foreign issuer) | Mar 25, 2019 | — |
| 424B5 | Prospectus supplement | Sep 15, 2017 | — |
| 424B5 | Prospectus supplement | Sep 13, 2017 | — |
| 424B5 | Prospectus supplement | Sep 13, 2017 | — |
| 424B5 | Prospectus supplement | May 26, 2017 | — |
| 424B4 | Prospectus | Feb 6, 2017 | — |
| POS AM | Amended registration statement | Jan 31, 2017 | — |
| POS AM | Post-effective amendment no. 2 to form f-1 | Jan 26, 2017 | — |
| F-3/A | Amendment no. 2 to form f-3 | Dec 12, 2016 | — |
| F-3/A | Pre-effective amendment no. 1 to form f-3 | Nov 29, 2016 | — |
| F-3 | Shelf registration (foreign issuer) | Nov 4, 2016 | — |
| 424B4 | Prospectus | Feb 3, 2016 | — |
| POS AM | Filing | Jan 22, 2016 | — |
| 424B4 | Prospectus | May 13, 2015 | — |
| F-1/A | Amended registration statement | May 6, 2015 | — |
| F-1/A | Registration statement to amendment no. 4 | Apr 30, 2015 | — |
| F-1/A | Filing | Apr 28, 2015 | — |
| F-6 | Form f-6 | Apr 10, 2015 | — |
| FWP | Free writing prospectus | Apr 10, 2015 | — |
| F-1/A | Amended registration statement | Apr 8, 2015 | — |
| F-1/A | Amended registration statement | Apr 6, 2015 | — |
| F-1 | Registration statement (foreign issuer) | Dec 29, 2014 | — |
Showing 65 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- SCNI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Jerusalem, Israel
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1611747
- Former names
- BiondVax Pharmaceuticals Ltd. (until Aug 28, 2023)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.